Navigation Links
joimax® Inspires Thai-German Neurosurgery Congress Participants for TESSYS®
Date:10/11/2011

KARLSRUHE, Germany, October 11, 2011 /PRNewswire/ --

joimax® opened doors for the Thai-German Neurosurgery congress participants, under the patronage of the German Academy for Neurosurgery (GANS) and the presidency of the Director of the Clinic for Neurosurgery at the "Städtisches Klinikum" in Karlsruhe, Prof. Dr. med. Dr. h.c. Uwe Spetzger - this year taking place in Karlsruhe, South Germany, October 5 to 8.

joimax® organised a lunch symposium in line with the congress, beginning with a company conducted tour through the facility where the participants visited amongst others the departments of the technical staff, research, development and construction - the core competencies and heart of the company. Also interesting were the explanations of the company founder and managing director Wolfgang Ries speaking about the exhibits in the so called internal "museum", documenting the development of the 10 years company history, showing prototypes of instruments, endoscopes and devices from the founding years.

The application of TESSYS® was presented by Prof. Dr. med. Jürgen Kiwit, Chief Physician of the Helios Hospital for Neurosurgery in Berlin Buch, in his demonstrative lecture with many pictures and videos. "In my opinion the minimally invasive TESSYS® method is the future of spine surgery, especially when treating herniated discs and stenosis.  The advantages of this gentle method are more than obvious," he stated.

The full potential of the endoscopic spinal surgery was impressively shown by Wolfgang Ries in his overview presentation: with special instruments it is also suitable for treating e.g. spinal canal stenosis and so makes - besides the transforaminal - the interlaminar access possible also, so that the spinal canal is now accessible from all sides, meaning 360°. The instruments of the next generation with flexible forceps, reamers and endoscopes are already very advanced in the joimax® development pipeline. An endoscopic assisted spine stabilisation system will open further wide ranges of applications.

A concluding hands-on with the latest joimax® endoscopic devices on models fully convinced the 45 Thai-German guests of the company's innovative performance.

About joimax® Company Profile

The innovative medical technology company joimax® dedicates itself to combined surgical technologies, particularly to minimally invasive spinal procedures ("joined minimal access technologies"). joimax® focuses on development, manufacturing and marketing of the technology and methods for integrated endoscopic surgical access to the spinal column, with optimized visualization. The joimax® fully integrated visualization, documentation and tissue removal technologies enable surgeons to conduct their operations independently in a cost effective manner. With the comprehensive education program CM3 which incorporates cadaver workshops, visitations and surgeries accompanied by experienced medical trainers and application specialists, the implementation of the procedure is supported right from the start. joimax® considers itself a partner of operating physicians, living  the motto "helping to treat patients!".

joimax®, TES®, TESSYS®, iLESSYS®, CESSYS®, EndoLIF®, Vitegra®, Camsource®, Shrill®, Versicon®, Endovapor®,  Vaporflex®, Legato®, Tigrip® and SPOT® are registered trademarks of the joimax® GmbH.

For further information and pictures please contact:
joimax GmbH
Dagmar Kyewski
Amalienbadstr. 41
RaumFabrik 61
D76227 Karlsruhe
Germany
Ph: +49(0)721-25514-0
info@joimax.com
http://www.joimax.com



'/>"/>
SOURCE joimax GmbH
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. UT professors pathogen research inspires robotics design for medicine and military
2. Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition
3. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show
4. Cardon Children's Medical Center Adopts TrueVision 3D Surgical Visualization Platform for Department of Pediatric Neurosurgery
5. Neurosurgery Journal Issues Supplement Dedicated to CyberKnife Radiosurgery Experience
6. Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress
7. Dr. Isaac Eliaz Gives Keynote Address at Annual Congressional Cancer Reception
8. HeartWare Completes GLP Studies of Next Generation MVAD® Pump; Data Presented Today at ISRBP Congress
9. FDA, NIH to Speak at CBIs 14th Annual Registries and Post-Approval Studies Congress
10. Generex Announces U.S. Congressman Curt Weldon, Co-Founder of the Congressional Diabetes Caucus, to Champion Generex Initiatives in Asia and North America
11. ERA-EDTA Congress 2011: Late Breaking Clinical Trials I
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 6, 2016 According to a new market ... (Polymer, Glass, Silicon), Application (Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental, ... global market is projected to reach USD 8.78 Billion by 2021 ... during the forecast period (2016 to 2021). ... ...
(Date:12/6/2016)... , Dec. 6, 2016  SRI International has ... million from the National Institutes of Health,s National ... Division of AIDS (NIAID-DAIDS) to support the manufacturing ... pre-exposure (PreP) agents. Under the seven-year contract, SRI ... development services for candidate HIV-prevention products that emerge ...
(Date:12/6/2016)... ... 2016 , ... RoviSys, a leading independent provider of comprehensive ... the opening of their new office building today. Located at 480 Green Oaks ... 200 employees focused on providing sales, engineering, and support services to customers in ...
(Date:12/5/2016)... Dec 5, 2016 Research and Markets ... - Technologies, Markets and Companies" to their offering. ... , , ... discovery using various -omics technologies such as proteomics and metabolomics. Molecular ... tests are also based on biomarker. Currently the most ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/22/2016)... June 22, 2016  The American College of Medical Genetics ... Executive Magazine as one of the fastest-growing trade shows ... at the Bellagio in Las Vegas . ... percentage of growth in each of the following categories: net ... and number of attendees. The 2015 ACMG Annual Meeting was ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
Breaking Biology News(10 mins):